PM360 Magazine Names Jennifer Wagner of Momentum Life Sciences to 2025 Elite 100 for Transformational Leadership

INDIANAPOLIS, May 14, 2025 /PRNewswire/ — Momentum Life Sciences proudly announces that Jennifer Wagner, Vice President of Client Solutions, has been selected for the prestigious 2025 Elite 100 by PM360 Magazine in the Transformational Leadership category for her exceptional impact on healthcare innovation and delivery. Wagner has distinguished herself by successfully bridging innovation with implementation, fundamentally changing how the industry approaches patient support. She embodies what it means to be a transformational leader—someone who doesn’t just envision change but systematically implements it.

During her tenure at Momentum, Wagner has built her reputation on recognizing that effective healthcare requires addressing both clinical and practical patient challenges. Her forward-thinking approach has resulted in patient engagement strategies that deliver measurable outcomes while maintaining exceptional quality standards.

A cornerstone of Wagner’s leadership has been her organizational innovation in team structure. She pioneered a cross-functional approach that replaces traditional siloed account management, enabling team members to develop broader expertise across therapeutic areas. This methodology has created a more adaptable, client-focused service model that responds more effectively to evolving healthcare needs, resulting in expanded capabilities across multiple therapeutic areas and enhanced client retention.

The impact of Wagner’s initiatives is clear: her programs have reached over 100,000 patients and provided training to more than 15,000 healthcare professionals, consistently achieving near-perfect satisfaction scores of 98-100%. Her hand in the creation of OneVoice™ resulted in a comprehensive support system where dedicated Clinical Nurse Educators address the logistical, clinical, and emotional aspects of patient care.

Andrea Heslin Smiley, CEO of Momentum Life Sciences recognized her transformational impact not just on patients but also on the organization, said “She always finds a way to be the best version of herself and applies that to her team and the work that we do.”

PM360 is a leading publication for marketing decision makers in the pharmaceutical and biotech industries, with the Elite 100 recognition celebrating individuals who are driving meaningful change in healthcare marketing and patient engagement. Elite 100 nominations are judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts.

Momentum Life Sciences delivers patient engagement solutions that combine human connection with advanced technology and real-world data, creating personalized support environments. The company’s 25+ years of experience informs its approach to optimizing patient interventions.

Contact:
Elizabeth Johnston
215-801-0227
395197@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/pm360-magazine-names-jennifer-wagner-of-momentum-life-sciences-to-2025-elite-100-for-transformational-leadership-302454725.html

SOURCE Momentum Life Sciences

Staff

Recent Posts

Kanazawa University research: High-speed AFM imaging reveals how brain enzyme forms dodecameric ring structure

KANAZAWA, Japan, Dec. 26, 2025 /PRNewswire/ -- Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa…

1 hour ago

Arspura Showcases a New Standard for Healthy Kitchen Living at CES 2026

LOS ANGELES, Dec. 25, 2025 /PRNewswire/ -- From January 6–9, 2026, visitors can experience Arspura's…

7 hours ago

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the…

16 hours ago

Relapse Risk Increases During the Holidays; Desert Hope Treatment Center Urges Early Support

LAS VEGAS, Dec. 24, 2025 (GLOBE NEWSWIRE) -- This holiday season, addiction experts at Desert Hope…

16 hours ago

Profound Medical Corp. Announces Upsize of Private Placement

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the…

16 hours ago